Abstract
Adult-onset type II citrullinemia (CTLN2) is characterized by a liver-specific deficiency of argininosuccinate synthetase (ASS) protein. We have recently identified the gene responsible for CTLN2, viz., SLC25A13, which encodes a calcium-binding mitochondrial carrier protein, designated citrin, and found five mutations of the SLC25A13 gene in CTLN2 patients. In the present study, we have identified two novel mutations, 1800ins1 and R605X, in SLC25A13 mRNA and the SLC25A13 gene. Diagnostic analysis for the seven mutations in 103 CTLN2 patients diagnosed by biochemical and enzymatic studies has revealed that 102 patients had one or two of the seven mutations and 93 patients were homozygotes or compound heterozygotes. These results indicate that CTLN2 is caused by an abnormality in the SLC25A13 gene, and that our criteria for CTLN2 before DNA diagnosis are correct. Five of 22 patients from consanguineous unions have been shown to be compound heterozygotes, suggesting a high frequency of the mutated genes. The frequency of homozygotes is calculated to be more than 1 in 20,000 from carrier detection (6 in 400 individuals tested) in the Japanese population. We have detected no cross-reactive immune materials in the liver of CTLN2 patients with any of the seven mutations by Western blot analysis with anti-human citrin antibody. From these findings, we hypothesize that CTLN2 is caused by a complete deletion of citrin, although the mechanism of ASS deficiency is still unknown.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Arco A del, Satrústegui J (1998) Molecular cloning of aralar, a new member of the mitochondrial carrier superfamily that binds calcium and is present in human muscle and brain. J Biol Chem273: 23327–23334
Arco A del, Agudo M, Satrústegui J (2000) Characterization of a second member of the subfamily of calcium-binding mitochondrial carriers expressed in human non-excitable tissues. Biochem J 345:725–732
Cheung C-W, Cohen NS, Raijman L (1989) Channeling of urea cycle intermediates in situ in permeabilized hepatocytes. J Biol Chem 264: 4038–4044
Chow WC, Ng HS, Tan IK, Thum TY (1996) Case report: recurrent hyperammonaemic encephalopathy due to citrullinaemia in a 52 year old man. J Gastroenterol Hepatol 11: 621–625
Crackower MA, Sinasac DS, Lee JR, Herbrick J-A, Tsui L-C, Scherer SW (1999) Assignment of the SLC25A12 gene coding for the human calcium-binding mitochondrial solute carrier protein aralar to human chromosome 2q24. Cytogenet Cell Genet 87: 197–198
Imamura Y, Kobayashi K, Yamashita T, Saheki T, Ichiki H, Hashida S, Ishikawa E (1987) Clinical application of enzyme immunoassay in the analysis of citrullinemia. Clin Chim Acta 164: 201–208
Inose T (1952) Hepatocerebral degeneration, a special type. J Neuropathol Exp Neurol 11: 401–408
Kakinoki H, Kobayashi K, Terazono H, Nagata Y, Saheki T (1997) Mutations and DNA diagnoses of classical citrullinemia. Hum Mutat 9: 250–259
Kasahara M, Ohwada S, Takeichi T, Kaneko H, Tomomasa T, Morikawa A, Yonemura K, Asonuma K, Tanaka K, Kobayashi K, Saheki T, Takeyoshi I, Morishita Y (2000) Living-related liver transplantation for type II citrullinemia using a graft from heterozygote donor. Transplantation 70: (in press)
Kawamoto S, Strong RW, Kerlin P, Lynch SV, Steadman C, Kobayashi K, Nakagawa S, Matsunami H, Akatsu T, Saheki T (1997) Orthotopic liver transplantation for adult-onset type II citrullinemia. Clin Transplantation 11: 453–458
Kobayashi K, Saheki T, Imamura Y, Noda T, Inoue I, Matuo S, Hagihara S, Nomiyama H, Jinno Y, Shimada K (1986) Messenger RNA coding for argininosuccinate synthetase in citrullinemia. Am J Hum Genet 38: 667–680
Kobayashi K, Ichiki H, Saheki T, Tatsuno M, Uchiyama C, Nukada O, Yoda T (1987) Structure of an abnormal messenger RNA for argininosuccinate synthetase in citrullinemia. Hum Genet 76: 27–32
Kobayashi K, Jackson MJ, Tick DB, O’Brien WE, Beaudet AL (1990) Heterogeneity of mutations in argininosuccinate synthetase causing human citrullinemia. J Biol Chem 265: 11361–11367
Kobayashi K, Rosenbloom C, Beaudet AL, O’Brien WE (1991) Additional mutations in argininosuccinate synthetase causing citrullinemia. Mol Biol Med 8: 95–100
Kobayashi K, Shaheen N, Kumashiro R, Tanikawa K, O’Brien WE, Beaudet AL, Saheki T (1993) A search for the primary abnormality in adult-onset type II citrullinemia. Am J Hum Genet 53: 1024–1030
Kobayashi K, Shaheen N, Terazono H, Saheki T (1994) Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia. Am J Hum Genet 55: 1103–1112
Kobayashi K, Kakinoki H, Fukushige T, Shaheen N, Terazono H, Saheki T (1995a) Nature and frequency of mutations in the argininosuccinate synthetase gene that cause classical citrullinemia. Hum Genet 96: 454–463
Kobayashi K, Nakata M, Terazono H, Shinsato T, Saheki T (1995b) Pancreatic secretory trypsin inhibitor gene is highly expressed in the liver of adult-onset type II citrullinemia. FEBS Lett 372: 69–73
Kobayashi K, Horiuchi M, Saheki T (1997) Pancreatic secretory trypsin inhibitor as a diagnostic marker for adult-onset type II citrullinemia. Hepatology 25: 1160–1165
Kobayashi K, Sinasac DS, Iijima M, Boright AP, Begum L, Lee JR, Yasuda T, Ikeda S, Hirano R, Terazono H, Crackower MA, Kondo I, Tsui L-C, Scherer SW, Saheki T (1999) The gene mutated in adult-onset type II citrullinaemia encodes a putative mitochondrial carrier protein. Nature Genet 22: 159–163
Kobayashi K, Iijima M, Yasuda T, Sinasac DS, Yamaguchi N, Tsui L-C, Scherer SW, Saheki T (2000) Type II citrullinemia (citrin deficiency): a mysterious disease caused by a defect of calcium-binding mitochondrial carrier protein. In: Pochet R, Donato R, Haiech J, Heizmann CW, Gerke V (eds) Calcium: the molecular basis of calcium action in biology and medicine. Kluwer, Dordrecht, pp 557–579
McKusick VA (1998) Citrullinemia. In: McKusick VA (ed) Mendelian inheritance in man, 12th edn. Johns Hopkins University Press, Baltimore, pp 2093–2095
McMurray WC, Mohyuddin F, Rossiter RJ, Rathbun JC, Valentine GH, Koegler SJ, Zarfas DE (1962) Citrullinuria: a new aminoaciduria associated with mental retardation. Lancet I: 138
Miyakoshi T, Takahashi T, Kato M, Watanabe M, Ito C (1968) Abnormal citrulline metabolism of Inose-type hepatocerebral disease (in Japanese). Shinkeikagaku 7: 88–91
Onuki J, Nishimura S, Yoshino K, Takahashi H, Suzuki T, Abe K, Sakurabayashi S, Iwasa T, Hirano M, Kobayashi K, Saheki T (2000) Genetic abnormality in 2 brothers of a case with adult onset type II citrullinemia: trial of pre-onset genetic diagnosis (in Japanese). Acta Hepatologica Jpn 41: 555–560
Saheki T, Tsuda M, Takada S, Kusumi K, Katsunuma T (1980) Role of argininosuccinate synthetase in the regulation of urea synthesis in the rat and argininosuccinate synthetase-associated metabolic disorder in man. Adv Enzyme Regul 18: 221–238
Saheki T, Ueda A, Hosoya M, Kusumi K, Takada S, Tsuda M, Katsunuma T (1981) Qualitative and quantitative abnormalities of argininosuccinate synthetase in citrullinemia. Clin Chim Acta 109: 325–335
Saheki T, Ueda A, Iizima K, Yamada N, Kobayashi K, Takahashi K, Katsunuma T (1982) Argininosuccinate synthetase activity in cultured skin fibroblasts of citrullinemic patients. Clin Chim Acta 118: 93–97
Saheki T, Ueda A, Hosoya M, Sase M, Nakano K, Katsunuma T (1983a) Enzymatic analysis of citrullinemia (12 cases) in Japan. Adv Exp Med Biol 153: 63–76
Saheki T, Yagi Y, Sase M, Nakano K, Sato E (1983b) Immunohistochemical localization of argininosuccinate synthetase in the liver of control and citrullinemic patients. Biomed Res 4: 235–238
Saheki T, Nakano K, Kobayashi K, Imamura Y, Itakura Y, Sase M, Hagihara S, Matuo S (1985a) Analysis of the enzyme abnormality in eight cases of neonatal and infantile citrullinemia in Japan. J Inherit Metab Dis 8: 155–156
Saheki T, Sase M, Nakano K, Yagi Y (1985b) Arginine metabolism in citrullinemic patients. In: Mori A, Cohen BD, Lowen-thal A (eds) Guanidines. Plenum, New York, pp 149–158
Saheki T, Kobayashi K, Miura T, Hashimoto S, Ueno Y, Yamasaki T, Araki H, Nara H, Shiozaki Y, Sameshima Y, Suzuki M, Yamauchi Y, Sakazume Y, Akiyama K, Yamamura Y (1986) Serum amino acid pattern of type II citrullinemic patients and effect of oral administration of citrulline. J Clin Biochem Nutr 1: 129–142
Saheki T, Kobayashi K, Ichiki H, Matuo S, Tatsuno M, Imamura Y, Inoue I, Noda T, Hagihara S (1987a) Molecular basis of enzyme abnormalities in urea cycle disorders: with special reference to citrullinemia and argininosuccinic aciduria. Enzyme 38: 227–232
Saheki T, Kobayashi K, Inoue I (1987b) Hereditary disorders of the urea cycle in man: biochemical and molecular approaches. Rev Physiol Biochem Pharmacol 108: 21–68
Saheki T, Kobayashi K, Inoue I, Matuo S, Hagihara S, Noda T (1987c) Increased urinary excretion of argininosuccinate in type II citrullinemia. Clin Chim Acta 170: 297–304
Sase M, Kobayashi K, Imamura Y, Saheki T, Nakano K, Miura S, Mori M (1985) Level of translatable messenger RNA coding for argininosuccinate synthetase in the liver of the patients with quantitative-type citrullinemia. Hum Genet 69: 130–134
Shikata T, Oda M (1971) Nutritional form of hepatocerebral disease (in Japanese). Acta Hepatol Jpn 12: 22–33
Shiraki H, Yamamoto T, Yamada K, Shikata T (1962) An autopsied case of the “pseudoulegyria type” of the hepatocerebral disease (in Japanese). Psychiatr Neurol Jpn 64: 305–326
Sinasac DS, Crackower MA, Lee JR, Kobayashi K, Saheki T, Scherer SW, Tsui L-C (1999) Genomic structure of the adultonset type II citrullinemia gene, SLC25A13, and cloning and expression of its mouse homologue. Genomics 62: 289–292
Su T-S, Bock H-GO, Beaudet AL, O’Brien WE (1982) Molecular analysis of arginino succinate synthetase deficiency in human fibroblasts. J Clin Invest 70: 1334–1339
Todo S, Starzl TE, Tzakis A, Benkov KJ, Kalousek F, Saheki T, Tanikawa K, Fenton WA (1992) Orthotopic liver transplantation for urea cycle enzyme deficiency. Hepatology 15: 419–422
Tsujii T, Morita T, Matsuyama Y, Matsui T, Tamura M, Matsuoka Y (1976) Sibling cases of chronic recurrent hepatocerebral disease with hypercitrullinemia. Gastroenterol Jpn 11: 328–340
Walker JE (1992) The mitochondrial transporter family. Curr Opin Struct Biol 2: 519–526
Walser M (1983) Urea cycle disorders and other hereditary hyperammonemic syndrome. In: Stanbury JB, Wyngaarden JB, Frederikson DS, Goldstein JL, Brown MS (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 402–438
Yagi Y, Saheki T, Imamura Y, Kobayashi K, Sase M, Nakano K, Matuo S, Inoue I, Hagihara S, Noda T (1988) The heterogeneous distribution of argininosuccinate synthetase in the liver of type II citrullinemic patients: its specificity and possible clinical implications. Am J Clin Pathol 89: 735–741
Yajima Y, Hirasawa T, Saheki T (1982) Diurnal fluctuation of blood ammonia levels in adult-type citrullinemia. Tohoku J Exp Med 137: 213–220
Yazaki M, Ikeda S, Takei Y, Yanagisawa N, Matsunami H, Hashikura Y, Kawasaki S, Makuuchi M, Kobayashi K, Saheki T (1996) Complete neurological recovery of an adult patient with type II citrullinaemia after living related partial liver transplantation. Transplantation 62: 1679–1681
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Yasuda, T., Yamaguchi, N., Kobayashi, K. et al. Identification of two novel mutations in the SLC25A13 gene and detection of seven mutations in 102 patients with adult-onset type II citrullinemia. Hum Genet 107, 537–545 (2000). https://doi.org/10.1007/s004390000430
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s004390000430